Early Detection of Pancreatic Adenocarcinoma (PDAC) Using a Panel of Biomarkers

Inclusion criteria (Symptomatic patients): - Able and willing to give willing to sign a consent form - ≥18 years old - Suspected pancreatic diseases with symptoms including, but not limited to, diarrhoea, back pain, abdominal pain, nausea, vomiting, constipation or new onset diabetes Exclusion criteria (Symptomatic patients): - Current or prior treatment (chemotherapy, radiotherapy, surgical resection, biological therapy, and immunotherapy) for any malignancy other than basal cell carcinoma within 5 years of enrolment. Asymptomatic participants will be identified through the EUROPAC registry and will fulfil EUROPAC's eligibility criteria. Always talk to your doctor about whether this trial is right for you.